000 01105 a2200301 4500
005 20250515021141.0
264 0 _c20070112
008 200701s 0 0 eng d
022 _a0742-2091
024 7 _a10.1007/s10565-006-0034-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzyniarowski, P
245 0 0 _aThe antitrypanosomal drug melarsoprol competitively inhibits thiamin uptake in mouse neuroblastoma cells.
_h[electronic resource]
260 _bCell biology and toxicology
_cMay 2006
300 _a183-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aMelarsoprol
_xpharmacology
650 0 4 _aMice
650 0 4 _aNeuroblastoma
_xmetabolism
650 0 4 _aThiamine
_xpharmacokinetics
650 0 4 _aTrypanocidal Agents
_xpharmacology
700 1 _aBettendorff, L
700 1 _aSchweingruber, M E
773 0 _tCell biology and toxicology
_gvol. 22
_gno. 3
_gp. 183-7
856 4 0 _uhttps://doi.org/10.1007/s10565-006-0034-z
_zAvailable from publisher's website
999 _c16162718
_d16162718